| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
96,771 |
87,170 |
$11.40M |
| 0012A |
|
280 |
268 |
$15K |
| 0011A |
|
493 |
420 |
$14K |
| 0013A |
|
236 |
221 |
$12K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,563 |
3,324 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
105,319 |
75,504 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,275 |
3,309 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,889 |
1,267 |
$1K |
| 0003A |
|
15 |
14 |
$871.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,390 |
9,738 |
$545.78 |
| 0072A |
|
15 |
15 |
$150.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
797 |
657 |
$102.07 |
| 99406 |
|
312 |
307 |
$78.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,252 |
10,708 |
$17.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,264 |
8,462 |
$8.54 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
593 |
555 |
$7.65 |
| 99173 |
|
11,564 |
7,957 |
$3.81 |
| 82948 |
|
10,448 |
6,844 |
$2.71 |
| 81003 |
|
10,563 |
7,157 |
$1.96 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,073 |
3,269 |
$0.00 |
| 3079F |
|
2,458 |
1,995 |
$0.00 |
| 86580 |
|
1,643 |
1,190 |
$0.00 |
| 3074F |
|
2,922 |
2,427 |
$0.00 |
| 93000 |
|
5,003 |
3,440 |
$0.00 |
| 85018 |
|
6,539 |
4,525 |
$0.00 |
| 90688 |
|
6,208 |
4,879 |
$0.00 |
| 90686 |
|
741 |
529 |
$0.00 |
| 3044F |
|
890 |
736 |
$0.00 |
| 82270 |
|
54 |
30 |
$0.00 |
| 3075F |
|
1,423 |
1,138 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,335 |
2,580 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
296 |
221 |
$0.00 |
| 3052F |
|
323 |
255 |
$0.00 |
| 3080F |
|
1,074 |
848 |
$0.00 |
| 90620 |
|
73 |
53 |
$0.00 |
| 90651 |
|
429 |
287 |
$0.00 |
| 90739 |
|
44 |
27 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,045 |
910 |
$0.00 |
| 99441 |
|
612 |
433 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
275 |
262 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
50 |
50 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
281 |
146 |
$0.00 |
| 99000 |
|
2,269 |
1,411 |
$0.00 |
| 0134A |
|
17 |
13 |
$0.00 |
| 98967 |
|
1,828 |
1,676 |
$0.00 |
| 90732 |
|
106 |
72 |
$0.00 |
| 99443 |
|
321 |
243 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
739 |
479 |
$0.00 |
| 91301 |
|
99 |
98 |
$0.00 |
| 90619 |
|
89 |
57 |
$0.00 |
| 90656 |
|
19 |
12 |
$0.00 |
| 92552 |
|
11,021 |
7,616 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,567 |
2,553 |
$0.00 |
| 99442 |
|
21,054 |
12,964 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,326 |
2,113 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
370 |
246 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,861 |
1,262 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
230 |
206 |
$0.00 |
| 3051F |
|
543 |
448 |
$0.00 |
| 90715 |
|
569 |
399 |
$0.00 |
| 3078F |
|
3,686 |
3,000 |
$0.00 |
| 3046F |
|
2,221 |
1,783 |
$0.00 |
| 3077F |
|
2,912 |
2,295 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,468 |
915 |
$0.00 |
| 81025 |
|
1,750 |
1,238 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
401 |
254 |
$0.00 |
| 90746 |
|
259 |
221 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,422 |
1,572 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
679 |
434 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
481 |
282 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,115 |
1,673 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
30 |
29 |
$0.00 |
| 90734 |
|
104 |
70 |
$0.00 |
| 98966 |
|
214 |
196 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
56 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
151 |
77 |
$0.00 |
| 90630 |
|
22 |
22 |
$0.00 |
| 98968 |
|
107 |
101 |
$0.00 |
| 90633 |
|
85 |
51 |
$0.00 |
| 90661 |
|
60 |
34 |
$0.00 |
| 90658 |
|
793 |
636 |
$0.00 |
| 90707 |
|
38 |
25 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
43 |
24 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28 |
16 |
$0.00 |
| 90662 |
|
20 |
15 |
$0.00 |
| 83655 |
|
23 |
12 |
$0.00 |